Reuters Health Report

If you are having trouble viewing this email or would like to view it in your web browser, CLICK HERE

Good Morning Postlinuxeg, FRI 28 May 2010 
 
Prescription heroin helps addicts off street drugs
Text messages save pregnant Rwandan women
Tanning beds raise melanoma risk, U.S. study finds
Novozymes sees China's commercial cellulosic ethanol in 2013
Silencing approach saves monkeys from Ebola: study
Who to blame for flu? Maybe the U.S., study finds
U.S. Congress hears benefits of synthetic biology
Storm over J&J's child drug recall only grows
Prescribed heroin offers answer for worst addicts:study
AIDS funding squeeze puts lives at risk: report

Prescription heroin helps addicts off street drugs
May 28, 2010 05:18 AM ET
NEW YORK (Reuters Health) - Prescribing heroin to addicts who can't kick their habit helps them stay off street drugs, British researchers said Friday.

Full Article
Text messages save pregnant Rwandan women
May 28, 2010 08:15 AM ET
KIGALI (Reuters) - At midnight Valentine Uwingabire's back began to hurt. Her husband ran to tell Germaine Uwera, a community health worker in their village in the fertile foothills of Rwanda's Volcanoes National Park.

Full Article
Tanning beds raise melanoma risk, U.S. study finds
May 27, 2010 02:32 PM ET
CHICAGO (Reuters) - Indoor tanning beds sharply increase the risk of melanoma, the deadliest kind of skin cancer, and the risk increases over time, U.S. researchers said on Thursday, and others experts called for tighter regulation.

Full Article
Novozymes sees China's commercial cellulosic ethanol in 2013
May 28, 2010 05:19 AM ET
BEIJING (Reuters) - The world's top industrial enzymes producer, Novozymes A/S, said on Friday that it expects China to launch its first commercial cellulosic ethanol facility by 2013.

Full Article
Silencing approach saves monkeys from Ebola: study
May 28, 2010 09:31 AM ET
WASHINGTON (Reuters) - A gene silencing approach can save monkeys from high doses of the most lethal strain of Ebola virus in what researchers call the most viable route yet to treating the deadly and frightening infection.

Full Article
Who to blame for flu? Maybe the U.S., study finds
May 27, 2010 07:12 PM ET
CHICAGO (Reuters) - The United States may provide an incubating ground for some flu strains, helping them migrate to warmer climates, U.S. researchers said on Thursday.

Full Article
U.S. Congress hears benefits of synthetic biology
May 27, 2010 03:52 PM ET
WASHINGTON (Reuters) - Synthetic biology can be used to make nonpolluting fuel, instant vaccines against new diseases and inexpensive medicines, but it will take time, collaboration and a nurturing regulatory environment, scientists said on Thursday.

Full Article
Storm over J&J's child drug recall only grows
May 27, 2010 04:56 PM ET
WASHINGTON (Reuters) - Johnson & Johnson <JNJ.N was blasted by lawmakers on Thursday for its massive recall of children's medicines, as regulators said a string of recent manufacturing lapses could lead to civil or criminal charges.

Full Article
Prescribed heroin offers answer for worst addicts:study
May 27, 2010 07:08 PM ET
LONDON (Reuters) - Prescribing heroin to chronic addicts may be politically sensitive, but it is more effective than the substitute methadone at keeping drug abusers in treatment programmes, British scientists said on Friday.

Full Article
AIDS funding squeeze puts lives at risk: report
May 27, 2010 06:21 PM ET
LONDON (Reuters) - Backtracking by international donors in funding for HIV/AIDS may undermine years of progress and is already putting lives at risk, the health aid group Medecins Sans Frontieres (MSF) said on Thursday.

Full Article
 
 











REUTERS www.reuters.com
Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book.Details
Subscribe to other Reuters newsletters
Unsubscribe from this newsletter.


Forward to a friend Send this mailing to a friend or colleague


Reuters.com: Help and Contact Us | Advertise With Us | Mobile | Newsletters | RSS RSS Feed | Interactive TV | Labs | Reuters in Second Life | Archive | Site Index | Video Index

Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers

0 comentários: